Skip to main content
Eliza (Farmer) Chakravarty, MD, Rheumatology, Oklahoma City, OK, Oklahoma Children’s Hospital OU Health

ElizaFarmer(Farmer)ChakravartyMD

Rheumatology Oklahoma City, OK

Physician

Are you Dr. Chakravarty?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 51 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Eliza (Farmer) Chakravarty, MD is a rheumatologist in Oklahoma City, Oklahoma. She is currently licensed to practice medicine in Oklahoma and California. She is affiliated with Oklahoma Children’s Hospital OU Health and SSM Health St. Anthony Hospital - Oklahoma City.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 2001 - 2003
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterResidency, Internal Medicine, 1997 - 2001
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2024
  • OK State Medical License
    OK State Medical License 2011 - 2024
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Challenges in Reproductive Health in Rheumatic Disease
    Challenges in Reproductive Health in Rheumatic DiseaseJuly 11th, 2022
  • Should We Fear Covid Variants?
    Should We Fear Covid Variants?July 3rd, 2021
  • Coping with Re-Entry Anxiety
    Coping with Re-Entry AnxietyJune 8th, 2021
  • Join now to see all

Grant Support

  • Efficacy Of Abatacept In Patients With Diffuse Systemic SclerosisNational Center For Research Resources2008
  • Clinical Trial: Rituximab In Subjects With Moderate To Severe Systemic Lupus EryNational Center For Research Resources2008
  • Clinical Trial: Rituximab In Subjects With Isn/Rps Class III Or IV Lupus NephritNational Center For Research Resources2008
  • Treatment Of Active SLE And The Prevention Of Subsequent Lupus FlaresNational Center For Research Resources2007
  • Rituximab In Subjects With Isn/Rps Class III Or IV Lupus NephritisNational Center For Research Resources2007
  • Rituximab In Subjects With Moderate To Severe Systemic Lupus ErythematosusNational Center For Research Resources2006–2007

Professional Memberships

Hospital Affiliations